Chemokine receptor antagonists and methods of use thereof

Details for Australian Patent Application No. 2002352772 (hide)

Owner Millennium Pharmaceuticals, Inc. Kyowa Hakko Kogyo Co., Ltd.

Inventors Elder, Amy M; Nakasato, Yoshisuke; Ghosh, Shomir; Harriman, Geraldine C B; Mattia, Karen M; Ohshima, Etsuo; Carson, Kenneth G; Luly, Jay R

Agent Davies Collison Cave

Pub. Number AU-B-2002352772

PCT Number PCT/US02/36953

PCT Pub. Number WO2003/045942

Priority 09/989,086 21.11.01 US

Filing date 13 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 26 October 2006

International Classifications

C07D 405/00 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/4353 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/4525 (2006.01)

A61K 31/4535 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/527 (2006.01) - spiro-condensed

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/5513 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 09/989,086 21.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002352772

26 October 2006 Application Accepted

  Published as AU-B-2002352772

22 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352773-USER EQUIPMENT (UE) HAVING A HYBRID PARALLEL/SERIAL BUS IN- TERFACE

2002352771-PARALLEL CONCENTRATION, DESALTING AND DEPOSITION ONTO MALDI TARGETS